403 related articles for article (PubMed ID: 18552238)
1. Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis.
Kanjanabuch T; Siribamrungwong M; Khunprakant R; Kanjanabuch S; Jeungsmarn P; Achavanuntakul B; Pongpirul K; Park MS; Tungsanga K; Eiam-Ong S
Perit Dial Int; 2008 Jun; 28 Suppl 3():S107-13. PubMed ID: 18552238
[TBL] [Abstract][Full Text] [Related]
2. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
[TBL] [Abstract][Full Text] [Related]
3. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
[TBL] [Abstract][Full Text] [Related]
4. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
5. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
6. Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.
Ditsawanon P; Supasyndh O; Aramwit P
Clin Exp Nephrol; 2014 Feb; 18(1):10-5. PubMed ID: 23757048
[TBL] [Abstract][Full Text] [Related]
7. Natural changes in peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients: a retrospective, seven year cohort survey.
Hung KY; Huang JW; Tsai TJ; Chen WY
Artif Organs; 2000 Apr; 24(4):261-4. PubMed ID: 10816198
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
11. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
Krediet RT
Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of a simple area measurement method of mesothelial cells in continuous ambulatory peritoneal dialysis effluent].
Kuwamura M; Sakai K; Sano M; Namba S; Morita T
Rinsho Byori; 2012 Feb; 60(2):110-5. PubMed ID: 22568091
[TBL] [Abstract][Full Text] [Related]
13. The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.
Cho KH; Do JY; Park JW; Yoon KW; Kim YL
Perit Dial Int; 2013; 33(4):382-90. PubMed ID: 23284074
[TBL] [Abstract][Full Text] [Related]
14. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
15. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
Neri L; Viglino G; Cappelletti A; Gandolfo C; Cavalli PL
Adv Perit Dial; 2000; 16():174-6. PubMed ID: 11045287
[TBL] [Abstract][Full Text] [Related]
16. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.
Visser CE; Brouwer-Steenbergen JJ; Betjes MG; Koomen GC; Beelen RH; Krediet RT
Nephrol Dial Transplant; 1995; 10(1):64-9. PubMed ID: 7724031
[TBL] [Abstract][Full Text] [Related]
17. Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells.
Ishibashi Y; Sugimoto T; Ichikawa Y; Akatsuka A; Miyata T; Nangaku M; Tagawa H; Kurokawa K
Perit Dial Int; 2002; 22(1):11-21. PubMed ID: 11929138
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
Davies SJ; Bryan J; Phillips L; Russell GI
Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid increases peritoneal ultrafiltration volume in patients on CAPD.
Kuriyama S; Nakayama M; Tomonari H; Kawaguchi Y; Hosoya T
Perit Dial Int; 1999; 19(1):38-44. PubMed ID: 10201339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
